GLP-1 drugs are surgery in a pill, says Dr Muffazal Lakdawala

In a comprehensive discussion on the rise of GLP-1 weight loss drugs, experts unpacked the complexities of obesity in India. Senior Endocrinologist Dr Shashank Joshi explained the concept of the 'thin-fat Indians,' a phenotype where individuals store more fat at a normal BMI (body mass index), increasing health risks. Dr. Muffazal Lakdawala hailed the new medications as powerful enough to treat obesity as a disease for the first time in history, calling it as close to 'surgery in a pill' as possible. The experts, which included representatives from the pharmaceutical industry and patients, stressed that these are prescription drugs for modifying chronic disease and preventing complications, not for cosmetic weight loss. Patients shared personal journeys of overcoming stalled weight loss and regaining motivation, while also acknowledging the need for a long-term lifestyle strategy. The conversation also addressed the need for responsible use, broader accessibility, and removing the stigma associated with obesity.